Recombinant Anti-DLX3 antibody [EPR8762(2)] (ab178428)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR8762(2)] to DLX3
- Suitable for: IP, WB
- Reacts with: Rat, Human
Overview
-
Product name
Anti-DLX3 antibody [EPR8762(2)]
See all DLX3 primary antibodies -
Description
Rabbit monoclonal [EPR8762(2)] to DLX3 -
Host species
Rabbit -
Tested applications
Suitable for: IP, WBmore details
Unsuitable for: Flow Cyt,ICC/IF or IHC -
Species reactivity
Reacts with: Rat, Human
Does not react with: Mouse -
Immunogen
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human DLX3 aa 250 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: O60479 -
Positive control
- JAR and 293T cell line lysates; Human adult and fetal skin tissue lysates; Rat skin tissue lysate.
-
General notes
This antibody was developed through collaboration with the lab of Maria Morasso at the National Cancer Institute, NIH.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.5% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR8762(2) -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Isotype control
-
Positive Controls
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab178428 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
IP | 1/10 - 1/100. | |
WB | 1/1000 - 1/5000. Detects a band of approximately 40 kDa (predicted molecular weight: 32 kDa). |
Target
-
Function
Likely to play a regulatory role in the development of the ventral forebrain. May play a role in craniofacial patterning and morphogenesis. -
Involvement in disease
Defects in DLX3 are a cause of trichodentoosseous syndrome (TDO) [MIM:190320]. TDO is an autosomal dominant syndrome characterized by enamel hypoplasia and hypocalcification with associated strikingly curly hair.
Defects in DLX3 are the cause of amelogenesis imperfecta type 4 (AI4) [MIM:104510]; also known as amelogenesis imperfecta hypomaturation-hypoplastic type with taurodontism. AI4 is an autosomal dominant defect of enamel formation associated with enlarged pulp chambers. -
Sequence similarities
Belongs to the distal-less homeobox family.
Contains 1 homeobox DNA-binding domain. -
Cellular localization
Nucleus. - Information by UniProt
-
Database links
- Entrez Gene: 1747 Human
- Entrez Gene: 287638 Rat
- Omim: 600525 Human
- SwissProt: O60479 Human
- Unigene: 134194 Human
- Unigene: 104800 Rat
-
Alternative names
- AI4 antibody
- Distal less homeo box 3 antibody
- DLX 3 antibody
see all
Images
-
Western blot analysis on immunoprecipitation pellet from (1) Human fetal skin lysate or (2) 1XPBS (negative control) immunoprecipitated using ab178428 with HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
-
All lanes : Anti-DLX3 antibody [EPR8762(2)] (ab178428) at 1/1000 dilution
Lane 1 : JAR cell line lysate
Lane 2 : Human skin tissue lysate
Lane 3 : Rat skin tissue lysate
Lane 4 : 293T cell line lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat anti-rabbit HRP conjugated antibody
Developed using the ECL technique.
Predicted band size: 32 kDa
Protocols
Datasheets and documents
References (2)
ab178428 has been referenced in 2 publications.
- Bhattacharya S et al. DLX3-Dependent STAT3 Signaling in Keratinocytes Regulates Skin Immune Homeostasis. J Invest Dermatol 138:1052-1061 (2018). PubMed: 29246798
- Palazzo E et al. A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation. Cell Death Differ 24:717-730 (2017). ChIP . PubMed: 28186503